The Global veterinary vaccines Market Report, published by emergen research, offers an industry-wide assessment of the veterinary vaccines market, which is inclusive of the most crucial factors contributing to the growth of the industry. The latest research report comprises an extensive analysis of the micro- and macro-economic indicators that influence the global market development during the forecast period of 2020-2027.Increasing trend to use fewer antibiotics and growing use of vaccines to treat zoonotic disorders are boosting the veterinary vaccines market.
The current trends of the veterinary vaccines market, combined with a wide array of growth opportunities, key drivers, restraints, challenges, and other critical aspects, have been vividly detailed in the veterinary vaccines market report. Furthermore, the report takes into account various market dynamics, which, in turn, generate a plethora of developmental prospects for the leading players involved in the of the veterinary vaccines industry.
The veterinary/animal vaccines market is likely to expand rapidly, due to the growing use of vaccines to treat zoonotic disorders and increasing inclination to use fewer antibiotics. Moreover, the rising rate of incidence of livestock disorders is anticipated to propel the veterinary vaccines market further during the forecast period.However, during the forecast period, the global veterinary vaccines market is likely to be hampered by lack of appropriate standards and quality controls in veterinary vaccine production.
Get a sample of the report : https://www.emergenresearch.com/request-sample/426
Key Highlights of Report
In January 2020, Automazioni VX, Inc. entered into a cooperative agreement with Merck Animal Health, a division of Merck KGaA. The collaboration was aimed to launch Innoject Pro, a uniquely developed technology for subcutaneous injection vaccination of chicken. The technology can be utilized in conjunction with the Innovax vaccine by Merck Animal Health, which is used to safeguard poultry from bacterial infections.
The poultry segment is expected to lead the global veterinary vaccines market throughout the forecast period, expanding at a CAGR of 7.0%. The increased need for risk-free pet food, associated with a growing focus on developing new animal protection approaches, is estimated to drive the segment during the forecast period.
The injection segment is projected to retain the largest market share throughout the forecast period. Growth of the segment is attributable to increasing use of injection vaccines for protection of animal health. Injection vaccines play a crucial role in preventing and controlling the dissemination of disease outbreaks in both farm animals and livestock.
Throughout the forecast period, the inactivated segment is expected to dominate the market for veterinary vaccines. Inactivated vaccines are free from bacteria and suitable for rehabilitation, except in case of immunocompetent patients. These vaccines are usually compressed, which makes their shipping and preserving simple.
Due to growing prevalence of viral infections among livestock, including the Nipah virus infection, avian influenza, canine influenza, swine flu, and bird flu, the viral segment is expected to lead the market during the forecast period.
North America is expected to dominate the global market for veterinary vaccines during the forecast period, due to rising incidence of animal diseases and growing population of pets in the U.S.
Key market participants include Zoetis Inc., Bayer AG, Virbac SA, Merck KGaA, Eli Lilly and Company, Phibro Animal Health Corporation, Elanco Animal Health Incorporated, Aptimmune Biologics Inc., Dechra Pharmaceuticals PLC, and Laboratorios HIPRA, S.A.
Market Scope:
One of the report’s central components is the broad veterinary vaccines market segmentation that includes the product type gamut, application spectrum, end-user industry landscape, significant geographical regions, and the top market contenders. The key players’ financial positions, along with their gross profits, sales volumes, sales revenue, manufacturing costs, and other financial ratios, have been accurately gauged in the report. Furthermore, several analytical tools like investment assessment, SWOT analysis, and Porter’s Five Forces Analysis have been implemented by our analysts’ team to evaluate the production and distribution capacities of the veterinary vaccines market players.
Request a discount on the report : https://www.emergenresearch.com/request-discount/426
Emergen Research has segmented the global veterinary vaccines market based on type, administration path, technology, infection, and region.
Type Outlook (Revenue, USD Billion; 2017–2027)
- Poultry
- Swine
- Aquaculture
- Cattle
- Cat
- Dog
Administration Path Outlook (Revenue, USD Billion; 2017–2027)
- Oral
- Injection
- Spray/Immersion
Technology Outlook (Revenue, USD Billion; 2017–2027)
- Inactivated
- Live Attenuated
- Recombinant
- Toxoid
Infection Outlook (Revenue, USD Billion; 2017–2027)
- Fungal
- Bacterial
- Parasitic
- Viral
TOC of the global veterinary vaccines market report:
Chapter 1, describes the veterinary vaccines Introduction, market overview, product offerings, growth opportunities, market risks, driving forces, and challenges.
Chapter 2, analyzes the key manufacturers of veterinary vaccines , along with the sales, revenue, and price of veterinary vaccines , in the forecast period.
Chapter 3, studies the competitive situation among the major manufacturers and vendors, with sales, revenue, and market share.
Chapter 4, analyzes the global market by regions, with sales, revenue, and market share of veterinary vaccines , for each region, from 2020 to 2027.
Chapters 5, 6, 7, 8 and 9, analyze the veterinary vaccines market by type, application, regions, and manufacturers, with sales, revenue, and market share by key countries in these regions…Continued
Read More: https://www.emergenresearch.com/industry-report/veterinary-vaccines-market
Related reports:
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
